ICD Code A53.9
ICD code A53.9 is used to identify cases of syphilis when the specific type or stage of the infection is not specified.
Boost patient experience and your bottom line by automating patient cost estimates, payer underpayment detection, and contract optimization in one place.
What is ICD diagnosis code A53.9
ICD code A53.9 is syphilis that has not been specified as either primary, secondary, or late stage.
When to use ICD code A53.9
1. Patient presents with clinical signs or symptoms suggestive of syphilis, but the specific stage (primary, secondary, latent, or tertiary) cannot be determined.
2. Laboratory tests indicate a positive result for syphilis, but documentation does not specify the stage or type.
3. Medical record lacks sufficient detail to classify syphilis as congenital, neurosyphilis, or another specific form.
4. Patient history or examination reveals syphilis infection, but the provider is unable to assign a more specific diagnosis due to incomplete information.
5. Syphilis is confirmed, but the clinical documentation does not indicate whether the infection is early or late.
Billable CPT codes for ICD code A53.9
Relevant CPT codes that may be used to treat ICD code A53.9 include:
- 86592: Syphilis test, qualitative (e.g., VDRL, RPR, ART)
- 86593: Syphilis test, quantitative
- 86780: Treponema pallidum, confirmatory test (e.g., FTA-ABS, MHA-TP, TP-PA)
- 96372: Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular
- J0490: Injection, penicillin G benzathine, 600,000 units
These CPT codes are commonly associated with the diagnosis and treatment of ICD code A53.9.
Are you being underpaid for encounters with A53.9
See how MD Clarity’s RevFind software can automatically read your payer contracts and identify underpayments for CPT codes associated with ICD code A53.9. Schedule a demo today to ensure you’re capturing every dollar your practice has earned.
Get paid in full by bringing clarity to your revenue cycle
Related ICD Codes
Subscribe to the

Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox